Ticker
RNACCompany Name
CARTESIAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 388.89M | $ 160.32M | 41.23% |
3/31/2025 | $ 409.13M | $ 180.43M | 44.1% |
12/31/2024 | $ 435.02M | $ 212.61M | 48.87% |
9/30/2024 | $ 455.32M | $ 219.2M | 48.14% |
6/30/2024 | $ 347.74M | $ 87.23M | 25.08% |
3/31/2024 | $ 325.21M | $ 103.42M | 31.8% |
12/31/2023 | $ 305.05M | $ 76.91M | 25.21% |
9/30/2023 | $ 106.03M | $ 79.6M | 75.07% |
6/30/2023 | $ 139.51M | $ 112.03M | 80.3% |
3/31/2023 | $ 155.69M | $ 125.92M | 80.88% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for CARTESIAN THERAPEUTICS INC is calculated as follows: CashnEq [ $ 146.26M ] / Assets [ $ 181M ]
(=) Cash to Assets [ 80.81% ]
Minimum
Jun 30, 2024
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.89% |
average | 9.83% |
median | 6.44% |
std | 9.6% |